Olfarma ApS: Financial statements 2022
CVR: 40241167
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
Olfarma ApS (CVR 40241167) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 445,162 and a net result of DKK 42,700 compared with DKK 39,658 the year before. That is an increase of 514% compared with the year before. Equity in the 2022 report amounted to DKK 224,964. The solvency ratio was 21.6%.
- Gross Profit
- DKK 445,162
- Profit/Loss
- DKK 42,700
- Equity
- DKK 224,964
- Total Assets
- DKK 1,042,015
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 445 t. | 43 t. | 225 t. | - |
| 2021 | - | 73 t. | 40 t. | 86 t. | - |
| 2020 | 87 t. | 39 t. | 29 t. | 46 t. | - |
| 2019 | 42 t. | 11 t. | 7 t. | 17 t. | - |
Official annual report
Keep an eye on Olfarma ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Olfarma ApS has published its annual report for 2021. Gross profit came to DKK 72,502, and the net result was DKK 39,658.
About Olfarma ApS
Olfarma ApS is a Danish company of the type Anpartsselskab based in Hedehusene, founded in 2019. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Jørgen Claus Oldenburg. The company is owned by Jørgen Claus Oldenburg and Anne Merete Oldenburg. According to the 2025 annual report, the company had an average of 2 employees. In 2025, the company reported a gross profit of DKK 686,093 and a net result of DKK 14,104 compared with DKK 59,935 the year before. Equity in the 2025 report amounted to DKK 285,196.